论文部分内容阅读
目的探讨婴幼儿哮喘急性发作时采用妥洛特罗贴剂经皮给药治疗临床效果。方法婴幼儿哮喘患儿80例,随机分为对照组和观察组,每组40例,对照组采用平喘、抗炎、化痰、止咳等常规治疗,观察组采用加用妥洛特罗贴剂经皮给药治疗,对两组效果进行比较。结果观察组患儿总有效率为95%,对照组为80%,组间比较差异有统计学意义(P<0.05)。结论婴幼儿哮喘急性发作时采用妥洛特罗贴剂经皮给药治疗,改善患儿预后,保障患儿正常生长发育有非常重要的作用,值得临床普遍推广。
Objective To investigate the clinical effect of transdermal delivery of tulobuterol patch in infants with acute asthma. Methods 80 infants and young children with asthma were randomly divided into control group and observation group, 40 cases in each group. The control group was treated with conventional therapy such as asthma, anti-inflammatory, phlegm, Agent transdermal drug treatment, the effect of the two groups were compared. Results The total effective rate was 95% in the observation group and 80% in the control group. There was significant difference between the two groups (P <0.05). Conclusions The treatment of transdermal delivery of tulobuterol patch in infants and young children with acute onset of acute asthma can improve the prognosis of children and protect the normal growth and development of children. It is worth to be widely popularized in clinic.